PT2970903T - Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes - Google Patents

Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes

Info

Publication number
PT2970903T
PT2970903T PT147648257T PT14764825T PT2970903T PT 2970903 T PT2970903 T PT 2970903T PT 147648257 T PT147648257 T PT 147648257T PT 14764825 T PT14764825 T PT 14764825T PT 2970903 T PT2970903 T PT 2970903T
Authority
PT
Portugal
Prior art keywords
photoreceptors
stem cells
pluripotent stem
photoreceptor progenitors
progenitors produced
Prior art date
Application number
PT147648257T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Publication of PT2970903T publication Critical patent/PT2970903T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
PT147648257T 2013-03-15 2014-03-14 Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes PT2970903T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361793168P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PT2970903T true PT2970903T (pt) 2024-02-26

Family

ID=51537881

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147648257T PT2970903T (pt) 2013-03-15 2014-03-14 Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes

Country Status (14)

Country Link
US (5) US20160030490A1 (enExample)
EP (2) EP4292600A3 (enExample)
JP (4) JP6581966B2 (enExample)
KR (3) KR102527507B1 (enExample)
CN (2) CN118995611A (enExample)
AU (4) AU2014233403B2 (enExample)
CA (2) CA3177943A1 (enExample)
DK (1) DK2970903T3 (enExample)
ES (1) ES2970720T3 (enExample)
FI (1) FI2970903T3 (enExample)
HK (1) HK1222205A1 (enExample)
IL (5) IL294897B2 (enExample)
PT (1) PT2970903T (enExample)
WO (1) WO2014145108A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102527507B1 (ko) 2013-03-15 2023-04-28 아스텔라스 인스티튜트 포 리제너러티브 메디슨 만능 줄기 세포로부터 제조된 광수용기 및 광수용기 전구체
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
ES2980659T3 (es) * 2015-03-23 2024-10-02 Astellas Inst For Regenerative Medicine Ensayos mejorados de potencia de células de epitelio pigmentario retiniano (EPR) humano y progenitores de fotorreceptores
TWI711455B (zh) * 2015-05-13 2020-12-01 臺北榮民總醫院 多層視網膜細胞移植物
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
ES2922475T3 (es) 2015-09-08 2022-09-15 Sumitomo Pharma Co Ltd Método para producir células epiteliales pigmentarias de la retina
CN105567635A (zh) * 2016-02-21 2016-05-11 中国医科大学附属第一医院 一种改良的Neurobasal B27培养基、制备方法及应用
CN109219657A (zh) 2016-03-30 2019-01-15 阿斯特利亚斯生物治疗股份公司 少突胶质细胞祖细胞组合物
US20200087390A1 (en) 2016-12-21 2020-03-19 Amgen Inc. Anti-tnf alpha antibody formulations
IL268666B2 (en) * 2017-02-17 2025-06-01 Univ Sorbonne Feeder-free methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
GB201703058D0 (en) * 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
CN110573610B (zh) 2017-03-08 2025-01-28 住友制药株式会社 视网膜色素上皮细胞的制备方法
JP7360583B2 (ja) 2017-09-14 2023-10-13 国立研究開発法人理化学研究所 網膜組織の製造方法
US20200277571A1 (en) * 2017-09-14 2020-09-03 Riken Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter
WO2019078781A1 (en) 2017-10-17 2019-04-25 National University Of Singapore SYSTEMS AND METHODS FOR PRODUCING PHOTORECEPTOR PROGENITORS
AU2019256723B2 (en) 2018-04-20 2025-09-04 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
CN108795864B (zh) * 2018-05-24 2021-08-24 中山大学中山眼科中心 一种利用人诱导多能干细胞获得富含视锥及视杆细胞的类视网膜组织的方法
AU2019335025A1 (en) * 2018-09-07 2021-04-08 Hebecell Corporation Methods and compositions for retinal neuron generation in carrier-free 3D sphere suspension culture
IL281628B2 (en) * 2018-09-19 2025-06-01 Lineage Cell Therapeutics Inc Methods for differentiating pluripotent stem cells in dynamic suspension culture
CN109486766B (zh) * 2018-11-26 2021-05-07 中山大学 一种泪腺干细胞、泪腺干细胞的培养体系和培养方法
US11603518B2 (en) 2019-01-23 2023-03-14 Asterias Biotherapeutics, Inc. Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
BR112022024064A2 (pt) * 2020-05-29 2023-01-31 Fujifilm Cellular Dynamics Inc Bicamada de epitélio pigmentado da retina e fotorreceptores e uso dos mesmos
PH12022552993A1 (en) * 2020-05-29 2023-01-16 Fujifilm Cellular Dynamics Inc Retinal pigmented epithelium and photoreceptor dual cell aggregates and methods of use thereof
EP4269564A4 (en) * 2020-12-25 2025-03-05 Iregene Therapeutics Ltd CHEMICAL INDUCTION METHOD FOR PHOTORECEPTOR NEURONAL CELLS
CN112608883B (zh) * 2020-12-25 2023-02-24 武汉睿健医药科技有限公司 一种光感受器神经元细胞的化学诱导方法
KR102525093B1 (ko) * 2021-04-16 2023-04-27 가톨릭대학교 산학협력단 사람 신경능 유래 코 하비갑개 줄기세포를 유효성분으로 포함하는 망막변성질환 예방 또는 치료용 약학적 조성물
CN113388582A (zh) * 2021-06-21 2021-09-14 香港再生医学有限公司 促使iPSC分化为外周神经干细胞的方法及培养基和系统

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750196B1 (en) 1995-03-27 2004-06-15 Acorda Therapeutics Methods of treating disorders of the eye
US20030166276A1 (en) 2000-10-16 2003-09-04 Melissa Carpenter Cultures of human CNS neural stem cells
WO1999055838A1 (en) 1998-04-24 1999-11-04 University Of Nebraska Board Of Regents Compositions and methods for the characterization and transplantation of mammalian retinal stem cells
CA2377906A1 (en) 1999-07-16 2001-01-25 Prescient Neuropharma Inc. Methods for producing and preparing cells for cell therapy
WO2002074176A1 (en) 2001-03-16 2002-09-26 University Of Washington Methods for modulating neural activity in the retina
AU2002305053A1 (en) 2001-03-26 2002-10-08 University Of Washington Method of inducing proliferation of retinal stem cells
WO2004007749A2 (en) 2002-07-12 2004-01-22 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
AU2005207042B2 (en) 2004-01-23 2010-09-09 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
EP1783205B1 (en) 2004-06-18 2024-02-21 Riken Method of inducing the differentiation of embryonic stem cells into nerve by serum-free suspension culture
CA2583473A1 (en) * 2004-10-05 2007-04-04 University Of Georgia Research Foundation, Inc. Neuronal progenitors from feeder-free human embryonic stem cell culture
US7541186B2 (en) 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
WO2008045952A2 (en) 2006-10-10 2008-04-17 The Regents Of The University Of Michigan Photoreceptor precursor cells
JP5441099B2 (ja) 2007-01-18 2014-03-12 独立行政法人理化学研究所 視細胞への分化誘導方法
US9328328B2 (en) * 2009-08-24 2016-05-03 Wisconsin Alumni Research Foundation Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
EP2486126B1 (en) 2009-10-06 2017-12-06 SNU R & DB Foundation Method for differentiation into retinal cells from stem cells
US10793830B2 (en) 2009-11-05 2020-10-06 Riken Method for producing retinal tissue in vitro
ES2542226T3 (es) 2010-04-28 2015-08-03 Technische Universität Dresden Método para producir células progenitoras retinianas polarizadas a partir de células madre pluripotentes y su diferenciación para dar células del epitelio pigmentario retiniano
EP2709672B1 (en) 2011-05-18 2019-12-18 The Regents of The University of California Compositions and methods for treating retinal diseases
US10973854B2 (en) 2011-11-25 2021-04-13 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
KR20150045935A (ko) 2012-04-24 2015-04-29 더 브리검 앤드 우먼즈 하스피털, 인크. 다능성 세포를 다시 생성하는 방법
ES2688019T3 (es) * 2012-06-05 2018-10-30 The Regents Of The University Of California Métodos y composiciones para la producción acelerada de células epiteliales pigmentadas retinianas a partir de células pluripotentes
EP2860245B1 (en) 2012-06-08 2021-03-17 Sumitomo Chemical Company, Limited Method for producing ciliary marginal zone-like structure
US20140004086A1 (en) 2012-06-29 2014-01-02 Tissue Genesis Inc. Formation of cell aggregates
US20160175361A1 (en) 2014-03-14 2016-06-23 Advanced Cell Technology, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US20160175362A1 (en) 2014-03-14 2016-06-23 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
KR102527507B1 (ko) 2013-03-15 2023-04-28 아스텔라스 인스티튜트 포 리제너러티브 메디슨 만능 줄기 세포로부터 제조된 광수용기 및 광수용기 전구체
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
EP2796545A1 (en) 2013-04-26 2014-10-29 Université Pierre et Marie Curie (Paris 6) Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
WO2015025967A1 (ja) 2013-08-23 2015-02-26 住友化学株式会社 網膜組織及び網膜関連細胞の製造方法
WO2015068505A1 (ja) 2013-11-11 2015-05-14 住友化学株式会社 網膜色素上皮細胞の製造方法
MY184796A (en) 2013-12-11 2021-04-22 Sumitomo Chemical Co Method for manufacturing ciliary marginal zone-like structure
US10435667B2 (en) 2014-01-16 2019-10-08 The Johns Hopkins University Methods for forming three-dimensional human retinal tissue in vitro
US11724005B2 (en) 2014-01-17 2023-08-15 Sumitomo Chemical Company, Limited Method for manufacturing ciliary margin stem cells
GB201402692D0 (en) 2014-02-16 2014-04-02 Univ Newcastle Synthetic retina
JP6682446B2 (ja) 2014-10-24 2020-04-15 大日本住友製薬株式会社 網膜組織の製造方法
US10363256B2 (en) 2015-03-27 2019-07-30 University Of Washington Methods for treatment of retinal disease by photoreceptor gene expression modulation
CA2998091C (en) 2015-09-08 2024-06-11 Sumitomo Dainippon Pharma Co., Ltd. Method for producing retinal tissue
US11371003B2 (en) 2016-02-05 2022-06-28 Wisconsin Alumni Research Foundation Photoreceptor scaffold for in vitro modeling and transplantation therapy
US20210155895A1 (en) 2016-04-04 2021-05-27 Lineage Cell Therapeutics, Inc. Pluripotent Stem Cell-Derived 3D Retinal Tissue and Uses Thereof
EP3447129B1 (en) 2016-04-22 2022-07-20 Sumitomo Pharma Co., Ltd. Method for producing retinal tissue
CA3037436A1 (en) 2016-09-22 2018-03-29 Sorbonne Universite Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases
US10973855B2 (en) 2016-10-10 2021-04-13 Small Kent W Methods for treating macular degeneration
CA3044509A1 (en) 2016-11-25 2018-05-31 Riken Cell population for transplantation and method for producing same
WO2018132802A1 (en) 2017-01-13 2018-07-19 The Johns Hopkins University Retina regeneration with a tissue-and-technology prosthesis
IL268666B2 (en) 2017-02-17 2025-06-01 Univ Sorbonne Feeder-free methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
WO2019017492A1 (ja) 2017-07-20 2019-01-24 国立研究開発法人理化学研究所 連続的な上皮を含む網膜組織の成熟化方法
CA3071648A1 (en) 2017-07-31 2019-02-07 Biotime, Inc. Compositions and methods for restoring or preventing loss of vision caused by disease or traumatic injury
US20200368234A1 (en) 2017-08-10 2020-11-26 University Of Washington Photoreceptor gene modulator photoregulin 3 for treatment of retinal disease
US20200277571A1 (en) 2017-09-14 2020-09-03 Riken Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter
JP7360583B2 (ja) 2017-09-14 2023-10-13 国立研究開発法人理化学研究所 網膜組織の製造方法
GB201800546D0 (en) 2018-01-12 2018-02-28 Ucl Business Plc Treatment
EP3761998A1 (en) 2018-03-07 2021-01-13 Sorbonne Universite Compositions and methods for efficent amplification of retinal progenitors cells
US20210228741A1 (en) 2018-04-27 2021-07-29 University Of Washington Methods and compositions to stimulate retinal regeneration
US20210317403A1 (en) 2018-05-09 2021-10-14 The Regents Of The University Of Colorado, A Body Corporate Stem cell-derived cell cultures, stem cell-derived three dimensional tissue products, and methods of making and using the same

Also Published As

Publication number Publication date
IL276173B2 (en) 2023-02-01
ES2970720T3 (es) 2024-05-30
US20140294778A1 (en) 2014-10-02
AU2019253874A1 (en) 2019-11-14
JP2020031635A (ja) 2020-03-05
IL266775A (en) 2019-07-31
US20190321414A1 (en) 2019-10-24
EP2970903A1 (en) 2016-01-20
EP4292600A2 (en) 2023-12-20
IL307568A (en) 2023-12-01
AU2025283562A1 (en) 2026-01-15
AU2022201986B2 (en) 2025-09-18
US12558380B2 (en) 2026-02-24
HK1218931A1 (en) 2017-03-17
US20190290701A1 (en) 2019-09-26
KR102263956B1 (ko) 2021-06-11
KR102527507B1 (ko) 2023-04-28
KR20230058556A (ko) 2023-05-03
JP2022023092A (ja) 2022-02-07
IL294897A (en) 2022-09-01
US20220347228A1 (en) 2022-11-03
KR20210070394A (ko) 2021-06-14
AU2014233403A1 (en) 2015-10-08
IL276173B (en) 2022-10-01
EP2970903A4 (en) 2016-11-16
JP7245752B2 (ja) 2023-03-24
AU2022201986A1 (en) 2022-04-14
FI2970903T3 (fi) 2024-03-13
EP4292600A3 (en) 2024-04-10
IL241177B (en) 2019-06-30
JP2016515382A (ja) 2016-05-30
EP2970903B1 (en) 2023-12-13
CA2906815A1 (en) 2014-09-18
CN118995611A (zh) 2024-11-22
CN105378070A (zh) 2016-03-02
IL294897B2 (en) 2024-03-01
HK1222205A1 (zh) 2017-06-23
IL241177A0 (en) 2015-11-30
JP2024053564A (ja) 2024-04-15
CA3177943A1 (en) 2014-09-18
IL276173A (en) 2020-09-30
AU2014233403B2 (en) 2019-08-01
JP6581966B2 (ja) 2019-09-25
US20160030490A1 (en) 2016-02-04
KR20160002779A (ko) 2016-01-08
WO2014145108A1 (en) 2014-09-18
IL294897B1 (en) 2023-11-01
IL266775B (en) 2020-08-31
US10307444B2 (en) 2019-06-04
DK2970903T3 (da) 2024-02-19

Similar Documents

Publication Publication Date Title
IL276173A (en) Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
IL290547A (en) Antibodies and methods of use
IL250689B (en) Rearrangement of multipurpose stem cells
EP2967931B8 (en) Stent with tether interface
IL244495A0 (en) Anti-alpha-synuclein antibodies and methods of use
IL243425A0 (en) Formulations and methods based on antibodies
IL244643A0 (en) Anti-ly6e antibodies and methods of use
IL240219B (en) Measuring embryo development and implantation potential by timing parameters and first cytokinesis phenotype
IL241399A0 (en) The adult stem cell population from the heart
IL245272A0 (en) pif-transfected cells and methods of use
EP3054965A4 (en) Methods of preventing or reducing photoreceptor cell death
GB201310918D0 (en) Prosthesis
GB201401001D0 (en) Enzyme function probes
SG10201403640XA (en) Stem cells
GB201313068D0 (en) Apparatuses and methods for ananlysing charged species
GB201414992D0 (en) Resetting human pluripotent stem cells
GB201415368D0 (en) Resetting pluripotent stem cells
AP2014007636A0 (en) Biogas generation system and kit for biogas generation system
AU2013904175A0 (en) Stem cell line and use thereof
PH32013000882S1 (en) Bowl